Allelic imbalance in familial and sporadic prostate cancer at the putative human prostate cancer susceptibility locus, HPC1
1998

Allelic Imbalance in Prostate Cancer at HPC1

Sample size: 73 publication Evidence: low

Author Information

Author(s): WD Dunsmuir, SM Edwards, SR Lakhani, M Young, C Corbishley, RS Kirby, DP Dearnaley, A Dowe, A Ardern-Jones, J Kelly, RA Eeles

Primary Institution: Institute of Cancer Research

Hypothesis

Is there allelic imbalance at the HPC1 locus in familial and sporadic prostate cancer?

Conclusion

The incidence of allelic imbalance at HPC1 is low in both sporadic tumours and small prostate cancer families.

Supporting Evidence

  • Allelic imbalance was detected in approximately 7.5% of tumours.
  • Overall, 12% of tumours showed allelic imbalance at a minimum of one locus.
  • Rates of allelic imbalance at HPC1 are much lower than for other tumour types where TSGs have been lost.
  • Microsatellite instability was observed in four of the tumours analysed.

Takeaway

This study looked at prostate cancer in families and found that a specific gene area, HPC1, doesn't seem to be causing problems in most cases.

Methodology

DNA from tumour tissue was analyzed from familial and sporadic prostate cancer cases using specific genetic markers.

Limitations

The study primarily involved small families and may not represent larger familial cases or different racial groups.

Participant Demographics

Participants included small families with 3-5 affected members and sporadic cases, primarily Caucasian.

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication